Alprazolam 1 mg tablets recalled due to manufacturing contamination concerns
Direct Rx is recalling Alprazolam 1 mg tablets nationwide due to potential cross contamination at the manufacturer. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall is precautionary in nature, issued due to CGMP deviations and potential cross contamination with no reported illnesses or injuries. It meets the rubric criterion for low-risk contamination and voluntary precautionary recalls.
Plain-English summary
Alprazolam 1 mg tablets packaged in 30-tablet or 60-tablet bottles are being recalled by Direct Rx (Dawsonville, GA 30534). The recall affects approximately 349 bottles distributed nationwide in the United States.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified at the manufacturer. The repackaging firm determined there are potential product cross contamination concerns. No illnesses or injuries have been reported.
Consumers who possess affected Alprazolam tablets should stop using them and contact their healthcare provider or pharmacist for guidance. Consumers can verify whether their product is affected by checking the lot number and expiration date on their bottle against the FDA recall information.
The recalled product
- Product
- Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs per bottle, NDC 72189-213-30; b) 60 Tabs per bottle, NDC 72189-213-60; Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534.
- Manufacturer
- Direct Rx
- Category
- Drug — Benzodiazepine
- Hazard
- cross-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: a) 03FE2318
- Exp. 8/31/24
- b) 27FE2315
- 28FE2313
- 02MA2306
- 21SE2201
- 16NO2216
- 17NO2216
- 24FA2314
- 17FE2203
- 12AP2204
- 17MA2205
- Exp. 3/31/23
- 21JU2206
- 22JU2220
- 12JY2206
- Exp. 5/31/23
- 10AU2209
- Exp. 6/30/23
- 14DE2215
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27